News
CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...
BioNTech SE BNTX +3.21% Get Free Report reported a second-quarter per-share loss of $1.82 (1.60 euros) on Monday, up from a loss of 3.36 euros reported a year ago, compared to beating the consensus ...
A strategy of selecting stocks based on rapid revenue growth has outperformed the broad market over the decades.
Moderna, Inc.'s Q2 2025 earnings highlight a steep revenue decline post-pandemic, with just $0.1bn in revenue and a $(0.8bn) ...
Healthbeat on MSN2h
Sorting out Covid vaccine confusion: New and conflicting federal policies raise questions
If you want a Covid-19 shot this fall, will your employer’s health insurance plan pay for it? There’s no clear answer. But ...
The company reported a net loss of $825 million for the quarter. Additionally, Moderna announced a $300 million reduction at the high end of their 2025 projected revenue range due to a timing shift of ...
As the country continues to deal with the fallout of the infamous Jeffery Epstein files, The Root is taking a closer look at some of the most polarizing conspiracy theories in American history.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results